2013-05-14T14:35:49-05:00 2012-06-30 PricewaterhouseCoopers LLP 2001 MARKET ST SUITE 1700 PHILADELPHIA PA 19103 990 2011-07-01 236296135 THE INSTITUTE FOR CANCER RESEARCH % ANTHONY DIASIO VP OF FINANC INST 2157282457 333 COTTMAN AVENUE PHILADELPHIA PA 191112497 ANTHONY J DIASIO 2013-05-14 true 2673303000 2011 2016-02-24 21:20:13Z Verdi J DiSesa MD MBA 333 COTTMAN AVENUE PHILADELPHIA PA 19111 19701805 false X WWW.FCCC.EDU X 1944 DE TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. 25 23 483 85 0 23123236 17664707 0 0 1292884 1104330 643780 932768 25059900 19701805 240176 273255 0 0 24796609 23594337 0 0 0 7204699 5874722 32241484 29742314 -7181584 -10040509 79553596 136225031 57275787 53875401 22277809 82349630 TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. false false 21201810 203752 THE INSTITUTE FOR CANCER RESEARCH AND ITS RESEARCH PROGRAMS ARE RENOWNED WORLD-WIDE FOR THEIR WORK IN UNDERSTANDING BOTH NORMAL AND ABNORMAL CELL GROWTH. SCIENTISTS ARE INVOLVED IN STUDIES OF GENES THAT CAUSE OR INHIBIT CANCER GROWTH, VIROLOGY, IMMUNOLOGY, CHEMICAL CARCINOGENS, CELL GROWTH AND INTERACTION AND GENE EXPRESSION. IN RECENT YEARS, RESEARCH HAS INCREASINGLY EMPHASIZED MOLECULAR ONCOLOGY AND GENETICS, AREAS WHICH BRIDGE ADVANCING KNOWLEDGE FROM THE LABORATORY WITH NEW CLINICAL APPROACHES. 6333008 THE RESEARCH FACILITIES HAVE BEEN STRUCTURED TO FULFILL THE NEEDS OF THE MULTI-DISCIPLINARY RESEARCH PROGRAMS AT FOX CHASE CANCER CENTER. THE FACILITIES HAVE BEEN DESIGNED TO ENHANCE ONGOING RESEARCH BY SUPPLYING INFORMATION, REAGENTS, AND TECHNICAL EXPERTISE THAT ARE NOT READILY AVAILABLE TO THE INDIVIDUAL INVESTIGATOR. 27534818 true true false true false false false false true true false true false true false false true false false false false false false false false false false true true false false false false false false false true false false false false false true false false false false true 75 0 true 483 true false false false false false false false false false false X 25 23 true true false false false false false true true false false true true true true true true false true false NJ PA X ANTHONY DIASIO VP OF FINANC 2157283824 604 COTTMAN AVENUE CHELTENHAM PA 19012 X David G Marshall 1.0 X X 0 0 0 Louis E Della Penna Sr 1.0 X X 0 0 0 W Thacher Brown 1.0 X X 0 0 0 Margot Keith 1.0 X X 0 0 0 Peter McCausland 1.0 X X 0 0 0 Donald E Morel Jr PhD 1.0 X X 0 0 0 William J Avery 1.0 X X 0 0 0 Michael V Seiden MD PhD 10.0 X X 0 568156 32402 THOMAS W HOFMANN 1.0 X 0 0 0 G Morris Dorrance Jr 1.0 X 0 0 0 The Honorable Dwight Evans 1.0 X 0 0 0 Edward A Glickman 1.0 X 0 0 0 Michael J Heller Esq 1.0 X 0 0 0 JOHN W CONWAY JR 1.0 X 0 0 0 Geoffrey Kent 1.0 X 0 0 0 Philip E Lippincott 1.0 X 0 0 0 Jill Michal 1.0 X 0 0 0 Edward J Roach 1.0 X 0 0 0 Thomas Shenk PhD 1.0 X 0 0 0 Pamela Strisofsky 1.0 X 0 0 0 William Stulginsky 1.0 X 0 0 0 Thomas R Tritton PhD 1.0 X 0 0 0 Kenneth E Weg 1.0 X 0 0 0 Yoram Wind PhD 1.0 X 0 0 0 Zane Wolf PhD 1.0 X 0 0 0 JOHN FULGONEY 1.0 X 0 0 0 ELIZABETH RIZOR 1.0 X 0 0 0 J Robert Beck MD 10.0 X 0 391719 19160 Paul F Engstrom MD 5.0 X 0 449017 31144 Thomas S Albanesi Jr 5.0 X 0 283465 20949 Robert Wilkens 10.0 X 0 217948 6427 Susan H Tofani 5.0 X 0 310953 6238 Gary J Weyhmuller 15.0 X 0 341885 32725 JONATHAN CHERNOFF 25.0 X 391591 0 21128 MARK SOBZCAK MD 1.0 X 0 534352 28728 MARK JOHNSON 4.0 X 0 0 0 JOANNE HAMBLETON 1.0 X 0 212954 9546 ERICA A GOLEMIS PHD 40.0 X 193531 0 30750 GLENN RALL 40.0 X 147056 0 24179 DAVID L WIEST 40.0 X 187766 0 27083 HARRY ROZMIAREK 40.0 X 201649 0 9489 RICHARD R HARDY PhD 40.0 X 167510 0 28712 HEINRICH RODER PhD 40.0 X 153545 0 28480 JOHN J GRICOSKI 40.0 X 158221 0 23401 CHRISTOPH SEEGER 40.0 X 149430 0 28300 Joseph F Hediger 1.0 X 0 300000 0 CHRISTOPHER J NASTO 1.0 X 0 130769 9510 1750299 3741218 418351 28 true true false JEANES HOSPITAL 7600 CENTRAL AVENUE PHILADELPHIA PA 19111 PROFESSIONAL SERVICE 2468781 ERNEST BOCK SONS INC 2800-A SOUTHAMPTON ROAD PHILADELPHIA PA 19154 PROFESSIONAL SERVICE 1295772 FISHER SCIENTIFIC INC PO BOX 3648 BOSTON MA 02241 PROFESSIONAL SERVICE 884989 OWENS MINOR INC PO BOX 8500-55182 PHILADELPHIA PA 19178 PROFESSIONAL SERVICE 803099 BRUKER BIOSPIN CORP PO BOX 200736 PITTSBURGH PA 15251 PROFESSIONAL SERVICE 656957 48 565471 17099236 17664707 0 1104330 1104330 0 729016 729016 0 0 0 0 MISCELLANEOUS REVENUE 900099 203752 203752 203752 19701805 203752 1833346 0 273255 273255 0 0 1091895 1091895 0 16826040 15034246 1791794 0 5676402 5562873 113529 0 0 8923 2141 6782 0 4772 4772 0 0 1573433 2258084 -684651 0 96381 10602 85779 186583 98889 87694 0 4418108 3446125 971983 165212 153647 11565 0 228194 205374 22820 1116939 860043 256896 -12064224 -10423481 -1640743 6061676 5152424 909252 111836 67101 44735 LABORATORY SUPPLIES 2942810 2942810 SUPPLIES & OTHER 1024079 798790 225289 29742314 27534818 2207496 0 2365615 1071676 0 0 1728420 7624185 -10751685 33055834 0 0 0 0 0 0 0 0 1748938 1188640 151279821 86150654 59560902 65129167 3660479 7482867 0 0 18862337 17870505 0 0 2378590 2802157 79553596 136225031 6462138 7470770 1469267 7343638 0 0 0 0 0 0 0 0 0 0 0 0 49344382 39060993 57275787 53875401 X 4407424 23585470 1055805 12278615 16814580 46485545 22277809 82349630 79553596 136225031 X -10040509 70112330 X false true true X true true X The American Oncologic Hospital Philadelphia PA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 4772 47718 4772 47718 29737542 354239462 29742314 354287180 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 157246 50284 61948 47718 317196 250000 250000 250000 250000 1000000 1500000 0 0 0 0 PART II-A, LINE 1 MANAGEMENT HAS DIRECT CONTACT WITH LEGISLATORS, THEIR STAFFS, AND GOVERMENT OFFICIALS TO ADVOCATE THE CENTER'S POSITION ON KEY ISSUES AFFECTING THE INSTITUTE FOR CANCER RESEARCH. FREQUENTLY, THESE CONTACTS ARE MADE TO EDUCATE THE APPROPRIATE REPRESENTATIVE OR OFFICIAL ON THE IMPLICATIONS OF SPECIFIC POLICY/LEGISLATION ON THE INDUSTURY IN GENERAL AND/OR IMPLICATIONS TO THE INSTITUTE FOR CANCER RESEARCH. AT THE FEDERAL LEVEL, DURING FY 2012, THE CENTER ADVOCATED FOR INCREASED MEDICARE REIMBURSEMENT UNDER THE CANCER CENTER RULES AND ADVOCATED FOR INCREASED RESEARCH FUNDING FOR THE NIH AND NCI. MANAGEMENT ALSO PROVIDED INPUT ON VARIOUS ISSUES INCLUDING HEALTH CARE REFORM AND IMPORTANT ISSUES SUCH AS DRUG SHORTAGES LEGISLATION. ADDITIONALLY, TO ASSIST THE CENTER OBTAIN NEEDED FUNDING FOR CUTTING EDGE TECHNOLOGIES AND RESOURCES USED BY THE SCIENTIFIC AND CLINICAL FACULTY, THE CENTER SUBMITTED FEDERAL GRANTS THROUGH THE APPROPRIATION MECHANISMS. AT THE STATE LEVEL, MANAGEMENT ADVOCATED FOR THE SUSTAINED USE OF TOBACCO FUNDS TO SUPPORT THE VARIOUS CANCER PROGRAMS IN THE COMMONWEALTH. THIS FUNDING IS CENTRAL TO THE PROGRAMS CONDUCTED BY THE CENTER IN CANCER RESEARCH, PREVENTION, SCREENING AND TREATMENT. MANAGEMENT ALSO MET WITH VARIOUS STATE REPRESENTATIVES TO OBTAIN FUNDING FOR CAPITAL AND OPERATING PROGRAMS UNDER THE VARIOUS APPROPRIATION MECHANISMS TO SUPPORT ECONOMIC DEVELOPMENT OPPORTUNITIES. false 3660479 -37331 -82030 110597 3430521 3161294 11573 750380 262768 3660479 3552556 1000 309714 76976 625000 3161294 8093846 279853 -1518099 16591 3286453 3552556 0.00000 1.00000 0.00000 61164 61164 107447038 62864805 44582233 503106 0 503106 40215118 22820430 17394688 3053395 465419 2587976 65129167 REAL ESTATE INVESTENTS 4560000 F FUNDS HELD IN TRUST 13310505 F 17870505 0 SECURITY DEPOSIT 4000 LONG TERM WORKERS COMPENSATION 3358389 POST RETIREMENT BENEFITS 941798 CAFETERIA IMPROVEMENTS 1510623 FAS 112 COSTS 261000 ANNUITY PAYMENTS 350117 TAX EXEMPT BOND LIAB-DUE TO AOH 32635066 39060993 PART V LINE 4 APPOINTMENT TO AN ENDOWED CHAIR REWARDS A SCIENTIST'S PROFESSIONAL CONTRIBUTIONS, RECOGNIZES THE VALUE OF HIS OR HER RESEARCH ENDEAVORS AND SAFEGUARDS THE FUNDING NEEDED TO CONTINUE THESE PIONEERING INQUIRIES. THOSE WHO SUPPORT A CHAIR ENDOWMENT BECOME VITAL PARTNERS IN OUR SCIENTIST GROUNDBREAKING, LIFESAVING DISCOVERIES. ENDOWING AND NAMING A CHAIR PROVIDES THE OPPORTUNITY TO HONOR A LOVED ONE WITH A MEMORIAL THAT WILL LAST FOR MANY, MANY YEARS. ENDOWED CHAIRS PROVIDE A STEADY AND PREDICTABLE FLOW OF FUNDS IN PERPETUITY, ALLOWING THE INSTITUTION TO STRENGTHEN THE QUALITY OF ITS PROGRAMS AND SERVICES BEYOND LEVELS THAT OTHER FUNDING SOURCES ALONE COULD SUPPORT. BOARD DESIGNATED FUNDS GIVE THE INSTITUTE FOR CANCER RESEARCH THE FLEXIBLE FUNDING TO INITIATE NEW RESEARCH PROGRAMS FOR THE PREVENTION, DETECTION, AND TREATMENT OF CANCER. THE FUNDS ASSIST PATIENTS AND THEIR FAMILIES RECEIVE THE BEST SUPPORT AND PROVIDE IMPORTANT SERVICES TO THE COMMUNITY. true ICR POSTDOCTORAL FELLOWSHIP 1 30405 0 N/A REIMANN FELLOWSHIP 3 4616 0 N/A WILLIAM J AVERY ENDOWED POSTDOCTORAL FELLOWSHIP 3 30405 0 N/A BOARD OF ASSOCIATES PLAIN & FANCY FELLOWSHIP 1 16552 0 N/A N/A ELIZABETH KNIGHT PATTERSON FELLOWSHIP 1 23999 0 N/A LAWRENCE GREENWALD POSTDOCTORAL FELLOWSHIP 2 63927 0 N/A GREENBERG FELLOWSHIP 7 78698 0 N/A F.M. KIRBY POSTDOCTORAL FELLOWSHIP 4 24653 0 N/A PART I LINE 2 THE APPOINTMENT FOR POSTDOCTORAL TRAINING CAN BEGIN UPON COMPLETION OF ALL REQUIREMENTS FOR THE DOCTORAL DEGREE. THOSE APPOINTED UNDER THE TRAINING GRANTS FOR NCI MAY HAVE NO MORE THAN THREE YEARS OF POSTDOCTORAL EXPERIENCE AND MUST BE A U.S. CITIZEN OR PERMANENT RESIDENCE. THESE PROGRAMS EMPHASIZE MENTORED RESEARCH SUPERVISION, MULTIDISCIPLINARY SEMINARS, CLINICAL ROUNDS, WORKSHOPS IN RESEARCH TECHNOLOGY AND IN SCIENTIFIC WRITING, GRANT AND MANUSCRIPT CRITICAL REVIEW. true false false false false false false false false Michael V Seiden MD PhD 0 493904 0 52000 0 22252 0 9800 0 22602 0 600558 0 0 J Robert Beck MD 0 347030 0 44689 0 0 0 9994 0 9166 0 410879 0 0 Paul F Engstrom MD 0 413617 0 35400 0 0 0 10079 0 21065 0 480161 0 0 Joseph F Hediger 0 0 0 0 0 300000 0 0 0 0 0 300000 0 0 Thomas S Albanesi Jr 0 246383 0 25000 0 12082 0 8615 0 12334 0 304414 0 0 Robert Wilkens 0 134615 0 0 0 83333 0 5385 0 1042 0 224375 0 0 Susan H Tofani 0 160731 0 11760 0 138462 0 4262 0 1976 0 317191 0 0 Gary J Weyhmuller 0 301885 0 40000 0 0 0 10123 0 22602 0 374610 0 0 HARRY ROZMIAREK 201649 0 0 0 0 0 8066 0 1423 0 211138 0 0 0 RICHARD R HARDY PhD 152010 0 15500 0 0 0 6628 0 22084 0 196222 0 0 0 HEINRICH RODER PhD 153545 0 0 0 0 0 6390 0 22090 0 182025 0 0 0 JONATHAN CHERNOFF 361162 0 30000 0 429 0 10464 0 10664 0 412719 0 0 0 ERICA A GOLEMIS PHD 170031 0 23500 0 0 0 7397 0 23353 0 224281 0 0 0 JOHN J GRICOSKI 149221 0 9000 0 0 0 6111 0 17290 0 181622 0 0 0 GLENN RALL 121056 0 26000 0 0 0 5704 0 18475 0 171235 0 0 0 CHRISTOPH SEEGER 149430 0 0 0 0 0 6225 0 22075 0 177730 0 0 0 DAVID L WIEST 134650 0 53116 0 0 0 7073 0 20010 0 214849 0 0 MARK SOBZCAK MD 0 370352 0 164000 0 0 0 9800 0 18928 0 563080 0 0 JOANNE HAMBLETON 0 202954 0 10000 0 0 0 8118 0 1428 0 222500 0 0 CHRISTOPHER J NASTO 0 53846 0 0 0 76923 0 3751 0 5759 0 140279 0 0 FORM 990, SCHEDULE J, PART I, LINE 4A IN 2011, JOSEPH F. HEDIGER RECEIVED A SEVERANCE PAYMENT OF $300,000, CHRISTOPHER J. NASTO RECEIVED A SEVERANCE PAYMENT OF $76,923, AND SUSAN H. TOFANI RECEIVED A SEVERANCE PAYMENT OF $138,462. PETER MCCAUSLAND - AIRGAS BOARD OF DIRECTOR 118258 SEE PART V false FORM 990, SCHEDULE L, PART IV THE INSTITUTE FOR CANCER RESEARCH CONDUCTS BUSINESS WITH AIRGAS ON A ROUTINE BASIS. AIRGAS IS A DISTRIBUTOR OF SPECIALIZED GASES. PETER MCCAUSLAND IS THE CEO AND A MAJOR SHAREHOLDER OF AIRGAS AND A MEMBER OF OUR BOARD OF DIRECTORS. THE TOTAL EXPENSES INCURRED DURING FY 2012 RELATED TO AIRGAS WERE $118,258. FORM 990 PART I, LINE 8 CONTRIBUTIONS REPORTED IN PART I, LINE 8 ARE ALLOCATED FROM FOX CHASE CANCER CENTER FOUNDATION, A RELATED ORGANIZATION, AND ARE INCLUDED ON FORM 990, SCHEDULE B, LIST OF CONTRIBUTORS. FORM 990 PART VI SECTION A LINE 3 MARK JOHNSON, AN EMPLOYEE OF FTI CONSULTING, WAS IN THE CAPACITY OF INTERIM SENIOR VICE PRESIDENT DURING FISCAL YEAR 2012. FTI CONSULTING RECEIVED COMPENSATION IN CONNECTION WITH SERVICES PROVIDED BY MARK JOHNSON TO THE ORGANIZATION, THE DETAILS OF WHICH ARE DISCLOSED IN SCHEDULE O. FORM 990 PART VI SECTION B LINE 11A THE FORM 990 IS PREPARED BY PWC AND REVIEWED BY THE FINANCE DEPARTMENT (INCLUDING THE VICE PRESIDENT - FINANCE AND MEMBERS OF THE ACCOUNTING STAFF), MEMBERS OF THE SENIOR LEADERSHIP COMMITTEE AND THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. After review by management and outside tax counsel, the 990 and 990T (if any) are posted to the website of the Secretarys Office. Each Board member is contacted and provided with the web address. A Board member without internet access is provided a paper copy to review. The website and paper mailing have an overview of the 990 and 990T preparation process and internal reviews. Each Board member is asked to review the 990 and 990T within 2 weeks and contact the Chief Financial Officer with any questions. FORM 990 PART VI SECTION A, LINE 2 LOUIS Della Penna is the father of ELIZABETH Rizor. FORM 990 PART VI SECTION A, LINE 4 In December 2011, an Affiliation Agreement was entered into between the Fox Chase entities and Temple University Health System. The Affiliation Agreement was contingent on a number of conditions, including among other things, Fox Chase reaching a Forbearance Agreement with its lenders, and TUHS securing the funding for the transaction through a bond offering. The Affiliation Agreement, which became effective as of July 1, 2012, provided TUHS with the ability to appoint the majority of the Board of Directors of the various Fox Chase entities, with the exception of Fox Chase Cancer Center corporation. As part of the agreement, The Fox Chase Cancer Center corporation changed its name to the Fox Chase Cancer Center Foundation. All permanently restricted assets of the Institute FOR CANCER RESEARCH and Hospital were transferred to the Foundation and the Foundation will use such assets to exclusively support the Institute For Cancer Research and The American Oncologic Hospital. Also as part of the Affiliation Agreement, the fixed assets and all employees of Health Services of Fox Chase Cancer Center became part of Fox Chase Medical Group, a newly formed corporation controlled by TUHS. Health Services will cease operations and will exist only to wind down its accounts receivable and accounts payable. FORM 990 PART VI SECTION B LINE 12C IN THE CASE OF POTENTIAL CONFLICT OF INTEREST OR COMMITMENT, THE PRESIDENT OF FCCC SHALL BE RESPONSIBLE FOR ADMINISTERING ALL MATTERS. ALL DISCLOSURES SHALL BE KEPT CONFIDENTIAL, IN A SEPARATE FILE UNDER THE CONTROL OF THE OFFICE OF THE PRESIDENT. THEY SHALL NOT BE MADE PART OF ANY PERSONNEL RECORDS OR THE BASIS FOR ANY REVIEW OF THE PERFORMANCE OF THE INDIVIDUAL STAFF MEMBER. ACCESS TO THESE RECORDS SHALL BE MADE AVAILABLE ONLY TO BOARD MEMBERS, THE PRESIDENT OR HIS DESIGNEE OR A PROPERLY AUTHORIZED GOVERNMENTAL BODY, ACTING UNDER STATUTORY OR REGULATORY AUTHORITY. RECORD WILL BE MAINTAINED FOR THREE YEARS UNLESS THE MATERIALS ARE SUBJECT TO GOVERNMENTAL ACTION. DISCLOSURES SHALL BE REQUIRED OF ALL STAFF AND BOARD MEMBERS AS FOLLOWS: BY BOARD MEMBERS: ALL BOARD MEMBERS OF THE INSTITUTE FOR CANCER RESEARCH SHALL BE REQUIRED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM AT THE TIME OF APPOINTMENT, ANNUALLY AND WHENEVER A NEW POTENTIAL CONFLICT ARISES. BY EMPLOYEES: ALL SCIENTISTS, PHYSICIANS AND ADMINISTRATIVE EMPLOYEES AT THE MANAGEMENT LEVEL AND ABOVE OF THE INSTITUTE FOR CANCER RESEARCH SHALL BE REQUIRED TO COMPLETE A CONFLICT OF INTEREST FORM AT THE TIME OF EMPLOYMENT, ANNUALLY AND WHENEVER A NEW POTENTIAL CONFLICT ARISES AND SUBMIT SUCH DISCLOSURE FORMS TO THE CHIEF ACADEMIC OFFICER OR HIS DESIGNEE. BY CONSULTANTS AND SUBCONTRACTORS: CONSULTANTS AND SUBCONTRACTORS SHALL CERTIFY TO THE INSTITUTE FOR CANCER RESEARCH THAT THEY ARE NOT IN A POSITION TO INFLUENCE INSTITUTE BUSINESS, RESEARCH OR OTHER DECISIONS IN WAYS THAT COULD LEAD TO ANY FORM OF PERSONAL GAIN FROM THEM OR THEIR FAMILY OR GIVE IMPROPER ADVANTAGE TO OTHERS TO THE INSTITUTE FOR CANCER RESEARCH'S DETRIMENT. FORM 990 PART VI SECTION B LINE 15B THE ORGANIZATION'S COMPENSATION POLICY FOR THE POSITIONS OF CEO, EXECUTIVE DIRECTORS, SENIOR MANAGEMENT, OFFICERS AND OR KEY EMPLOYEES IS TO UTILIZE A NATIONAL SURVEY FACILITY FOR COMPENSATION INFORMATION. ANNUALLY, IT IS REVIEWED BY THE ORGANIZATION'S EXECUTIVE COMMITTEE AS WELL AS THE FULL BOARD FOR APPROVAL. FORM 990 PART VI SECTION C LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC WHEN REQUESTED. FORM 990, PART VII MARK JOHNSON WAS IN THE CAPACITY OF INTERIM, SR. VICE PRESIDENT, CLINICAL SERVICES & BUSINESS DEVELOPMENT DURING FISCAL 2012 WHILE EMPLOYED BY FTI CONSULTING. INDIVIDUAL COMPENSATION IS NOT AVAILABLE FROM FTI. IN CONNECTION WITH SERVICES PROVIDED BY MARK JOHNSON TO THE ORGANIZATION FTI WAS PAID $220,119 BY FOX CHASE CANCER CENTER FOUNDATION IN FY12, AN AFFILIATE OF THE INSTITUTE FOR CANCER RESEARCH. FORM 990, PART XI, LINE 5 TRANSFERS FROM AFFILIATES 73,982,531 UNREALIZED GAINS/(LOSSES) (773,906) DECREASE IN POST RETIREMENT BENEFITS 711,184 CHANGE IN FMV OF INTEREST SWAP (2,412,180) LOSS FROM UNCOLLECTIBLE PLEDGES (931,412) ROUNDING ADJUSTMENT 37 INVESTMENT RETURN NET EARNINGS ALLOCATION (463,924) ___________ TOTAL 70,112,330 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:David G. Marshall TITLE:CHAIRMAN HOURS:4 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Louis E. Della Penna Sr. TITLE:VICE CHAIR HOURS:4 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:W. Thacher Brown TITLE:VICE CHAIR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Margot Keith TITLE:VICE CHAIR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Peter McCausland TITLE:VICE CHAIR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Donald E. Morel, Jr., Ph.D. TITLE:VICE CHAIR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:William J. Avery TITLE:CHAIR, EXECUTIVE COMMITTEE HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Michael V. Seiden, MD, Ph.D. TITLE:PRESIDENT & CEO HOURS:31 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:THOMAS W. HOFMANN TITLE:VICE CHAIR HOURS:5 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:G. Morris Dorrance, Jr. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:The Honorable Dwight Evans TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Edward A. Glickman TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Michael J. Heller, Esq. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:JOHN W. CONWAY, JR. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Geoffrey Kent TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Philip E. Lippincott TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Jill Michal TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Edward J. Roach TITLE:DIRECTOR HOURS:4 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Thomas Shenk, Ph.D. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Pamela Strisofsky TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:William Stulginsky TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Thomas R. Tritton, Ph.D. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Kenneth E. Weg TITLE:DIRECTOR HOURS:4 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Yoram Wind, Ph.D. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Zane Wolf, Ph.D. TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:JOHN FULGONEY TITLE:DIRECTOR HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:ELIZABETH RIZOR TITLE:PRESIDENT, BOARD OF ASSOC. HOURS:3 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:J. Robert Beck, MD TITLE:CHIEF ACADEMIC OFFICER HOURS:50 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Paul F. Engstrom, MD TITLE:CHIEF NETWORK OFFICER HOURS:55 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Thomas S. Albanesi, Jr. TITLE:CHIEF FINANCIAL OFFICER HOURS:60 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Robert Wilkens TITLE:CHIEF DEVELOPMENT OFFICER HOURS:40 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Susan H. Tofani TITLE:SR. VP, CLINICAL SERVICES HOURS:55 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Gary J. Weyhmuller TITLE:CHIEF OPERATING OFFICER HOURS:45 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:JONATHAN CHERNOFF TITLE:SENIOR VICE PRESIDENT HOURS:35 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:MARK SOBZCAK, M.D. TITLE:CHIEF NETWORK OFFICER HOURS:55 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:MARK JOHNSON TITLE:INTERIM, SR. VP CLINICAL SERV. HOURS:36 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:JOANNE HAMBLETON TITLE:SR. VP, CLINICAL SERVICES HOURS:45 HOURS DEVOTED FOR RELATED ORGANIZATION FORM 990 PART VII NAME:Joseph F. Hediger TITLE:FORMER OFFICER HOURS:1 FOX CHASE CANCER CENTER FOUNDATION 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 RESEARCH DE 501(C)(3) 7 NA false THE AMERICAN ONCOLOGIC HOSPITAL 333 COTTMAN AVENUE PHILADELPHIA PA 19111 231352156 PATIENT CARE PA 501(C)(3) 3 NA false HEALTH SERVICES OF FOX CHASE CANCER CENT 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232328543 PATIENT CARE PA 501(C)(3) 3 NA false FOX CHASE NETWORK 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232467337 CLINICAL SVCS PA 501(C)(3) 11B FCCC false FCCC SELECT 76 ST PAUL STREET BURLINGTON VT 05401 020597423 CAPTIVE INSUR VT 501(C)(3) 11A AOH false FOX CHASE LIMITED 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232396731 MEDICAL SERVI PA FCCC C CORP false true true false false false false false true true false true true true true true true true FORM 990, SCHEDULE R, PART II RELATED TAX-EXEMPT ENTITIES REPORTED ON SCHEDULE R, PART II OPERATE AS A INTEGRATED SYSTEM. THE AMERICAN ONCOLOGIC HOSPITAL ("AOH") GENERATES A MARGIN FROM THE OPERATIONS. THIS MARGIN IS USED TO FUND DEFICITS IN THE INSTITUTE FOR CANCER RESEARCH AND HEALTH SERVICES OF FOX CHASE CANCER CENTER. THESE ARE BELOW THE LINE TRANSFERS AND ARE REPORTED AS SUCH ON THIS FORM 990. IN ADDITION, AOH WAS REQUIRED TO MAKE A CAPITAL CONTRIBUTION TO FCCC SELECT TO FURTHER CAPITALIZE THE ENTITY. FOX CHASE CANCER CENTER FOUNDATION, EIN: 23-2003072, ADDRESS: 333 COTTMAN AVE., PHILA., PA 19111, EXPENSES: $52,168,006, EXCESS LOBBYING EXPENDITURES: $0 THE AMERICAN ONCOLOGIC HOSPITAL, EIN: 23-1352156, ADDRESS: 333 COTTMAN AVE, PHILA., PA 19111, EXPENSES: $224,586,477, EXCESS LOBBYING EXPENDITURES: $0 THE INSTITUTE FOR CANCER RESEARCH, EIN: 23-6296135, ADDRESS: 333 COTTMAN AVE., PHILA., PA 19111, EXPENSES $29,742,314, EXCESS LOBBYING EXPENDITURES: $0 HEALTH SERVICES OF FOX CHASE CANCER CENTER, EIN: 23-2328543, ADDRESS: 333 COTTMAN AVE., PHILA., PA 19111, EXPENSES $50,790,383, EXCESS LOBBYING EXPENDITURES: $0